| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |